2024-01-27 01:30:00 ET
Summary
- Seven IPOs priced this past week, led by 3 that raised $100+ million.
- Four very small Chinese issuers also began trading in the US this past week, all raising $10 million or less.
- Three listings are currently scheduled for the week ahead, although other issuers may join the calendar throughout the week.
Seven IPOs priced this past week, led by three that raised $100+ million.
After upwardly revising the terms earlier in the week, CG Oncology (CGON) further upsized the offering and priced above the range to raise $380 million at a $1.3 billion market cap. Its sole clinical asset is initially in development for a subclass of bladder cancer and is currently in an ongoing Phase 3 trial, with topline data expected by the end of 2024. If successful, the biotech believes that this trial could serve as the basis for a BLA submission. CG Oncology popped 96% on its first day and finished the week up 84%....
Read the full article on Seeking Alpha
For further details see:
U.S. IPO Weekly Recap: Biotech CG Oncology Pops 96% In A 7 IPO Week